What are the therapeutic implications of targeting PI3K?
Given its central role in various cellular processes and diseases, PI3K is an attractive target for therapeutic intervention. PI3K inhibitors are being developed and tested in clinical trials for different types of cancer. These inhibitors aim to block PI3K activity, thereby preventing tumor growth and progression. Additionally, modulating PI3K signaling offers potential therapeutic avenues for metabolic disorders and neurodegenerative diseases.
